Novartis AG NVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.90% | 2.82% | 5.20% | 8.38% | 11.86% |
| Total Other Revenue | -1.88% | 0.21% | 44.30% | 52.46% | 49.52% |
| Total Revenue | 1.76% | 2.73% | 6.31% | 9.57% | 12.88% |
| Cost of Revenue | 6.20% | 8.42% | 6.91% | 6.36% | 10.99% |
| Gross Profit | 0.37% | 0.96% | 6.11% | 10.63% | 13.48% |
| SG&A Expenses | -3.19% | -0.16% | 4.23% | 5.41% | 6.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 495.45% | 1.85% | 71.88% | 78.76% | -116.56% |
| Total Operating Expenses | 5.80% | 7.06% | 10.02% | 9.22% | 12.32% |
| Operating Income | -5.90% | -5.75% | -1.20% | 10.33% | 13.96% |
| Income Before Tax | -23.00% | -0.55% | 5.81% | 19.88% | 28.96% |
| Income Tax Expenses | 29.17% | 40.86% | 10.30% | 40.21% | 108.82% |
| Earnings from Continuing Operations | -30.38% | -6.53% | 5.09% | 16.99% | 22.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 80.00% | -37.50% | 2,100.00% | 750.00% | 150.00% |
| Net Income | -30.31% | -6.57% | 5.25% | 17.11% | -18.24% |
| EBIT | -5.90% | -5.75% | -1.20% | 10.33% | 13.96% |
| EBITDA | -4.36% | -3.97% | -0.21% | 8.77% | 11.79% |
| EPS Basic | -28.58% | -3.54% | 9.24% | 21.82% | -14.70% |
| Normalized Basic EPS | -7.50% | -6.48% | -1.40% | 11.31% | 17.64% |
| EPS Diluted | -28.36% | -3.40% | 9.18% | 21.54% | -14.76% |
| Normalized Diluted EPS | -7.34% | -6.38% | -1.33% | 11.37% | 17.63% |
| Average Basic Shares Outstanding | -2.63% | -3.31% | -3.80% | -3.97% | -3.81% |
| Average Diluted Shares Outstanding | -2.78% | -3.40% | -3.86% | -4.00% | -3.80% |
| Dividend Per Share | 20.81% | 20.81% | 20.81% | 20.81% | -1.44% |
| Payout Ratio | 0.66% | 0.24% | 0.06% | -0.12% | 0.25% |